Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 0.79 is in line with its 5-year average of 0.85, near the low end of its 5-year range (0.51–2.24).
As of the fiscal period ended Tuesday, June 30, 2026. 21.77% above its 12-month average of 0.65.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.79.
QUICK RATIO (ACID-TEST)
0.79
QUICK RATIO (ACID-TEST) AVG TTM
0.65
QUICK RATIO (ACID-TEST) AVG 3Y
0.67
QUICK RATIO (ACID-TEST) AVG 5Y
0.85
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+21.77%
CURRENT VS 3Y AVG
+16.90%
CURRENT VS 5Y AVG
-7.80%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
-76.55%
vs the sector median at left
AirSculpt Technologies, Inc.
Market Cap
$131.21M
Quick Ratio (Acid-Test)
0.79
TTM Avg
0.65
3Y Avg
0.67
5Y Avg
0.85
Market Cap
$130.79M
Quick Ratio (Acid-Test)
2.70
TTM Avg
1.66
3Y Avg
3.23
5Y Avg
3.69
Market Cap
$127.98M
Quick Ratio (Acid-Test)
1.34
TTM Avg
5.45
3Y Avg
5.41
5Y Avg
6.46
Market Cap
$127.29M
Quick Ratio (Acid-Test)
0.86
TTM Avg
0.23
3Y Avg
0.62
5Y Avg
0.88
Market Cap
$136.57M
Quick Ratio (Acid-Test)
1.07
TTM Avg
2.33
3Y Avg
2.66
5Y Avg
3.76
Market Cap
$136.67M
Quick Ratio (Acid-Test)
8.73
TTM Avg
6.53
3Y Avg
6.53
5Y Avg
6.53
Market Cap
$124.70M
Quick Ratio (Acid-Test)
8.98
TTM Avg
5.43
3Y Avg
7.69
5Y Avg
7.29
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AirSculpt Technologies, Inc. (AIRS) | $131.21M | 0.79 | 0.65 | 0.67 | 0.85 |
| Health Catalyst, Inc. (HCAT)vs › | $130.79M | 2.70 | 1.66 | 3.23 | 3.69 |
| LifeMD, Inc. (LFMD)vs › | $132.03M | 0.84 | 0.97 | 0.83 | 1.00 |
| Freenome, Inc. (FRNM)vs › | $133.45M | N/A | N/A | N/A | N/A |
| Pyxis Oncology, Inc. (PYXS)vs › | $127.98M | 1.34 | 5.45 | 5.41 | 6.46 |
| NRx Pharmaceuticals, Inc. (NRXP)vs › | $127.29M | 0.86 | 0.23 | 0.62 | 0.88 |
| Organigram Global Inc. (OGI)vs › | $136.57M | 1.07 | 2.33 | 2.66 | 3.76 |
| Atrium Therapeutics, Inc. (RNA)vs › | $136.67M | 8.73 | 6.53 | 6.53 | 6.53 |
| Entera Bio Ltd. (ENTX)vs › | $124.70M | 8.98 | 5.43 | 7.69 | 7.29 |
| KORU Medical Systems, Inc. (KRMD)vs › | $137.80M | 2.09 | 2.13 | 2.85 | 4.38 |
Quick Ratio
0.79
Excludes inventory
Current Ratio
0.79
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 0.79 |
| 2026-03-31 | 0.75 |
| 2025-12-31 | 0.55 |
| 2025-09-30 | 0.51 |
| 2025-06-30 | 0.64 |
| 2025-03-31 | 0.57 |
| 2024-12-31 | 0.60 |
| 2024-09-30 | 0.51 |
| 2024-06-30 | 0.86 |
| 2024-03-31 | 0.69 |
| 2023-12-31 | 0.79 |
| 2023-09-30 | 0.83 |
| 2023-06-30 | 1.12 |
| 2023-03-31 | 0.83 |
| 2022-12-31 | 0.75 |
| 2022-09-30 | 0.72 |
| 2022-06-30 | 2.24 |
| 2022-03-31 | 2.03 |
| 2021-12-31 | 1.79 |
| 2021-09-30 | 1.65 |
| 2021-06-30 | 1.28 |
| 2021-03-31 | 0.00 |
| 2020-12-31 | 1.22 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
